pharma
Hedge funds are bullish on these stocks. Read our stock analysis to find out why - and then form your own opinion. When multiple hedge funds pick up on a single stock, it’s definitely worth paying attention to. Hedge Fund Alpha’s stock analysis picks out the small-cap and under-the-radar stocks that multiple hedge funds are talking about. Providing coverage of several hedge fund letters in a single post, we share why those funds are long those stocks and any concerns they might have about them. In cases where there’s a short thesis facing off with a long thesis, we share both sides of the stock narrative. Check out our stock analysis page for all the hottest hedge fund stocks managers are talking about.
Pharma Bro Shkreli Guilty On 3 Counts, Questions Jury Verdict, Talks Appeal In Livestream After Twitter
100% Of Pharma Earnings Growth Last Year Came From Price Rises
Pharmaceuticals And Biotech Are A Hot Space For Activists Right Now
Boosted By Shorts In Pharma “Price Gouging” Stocks, Raging Capital Up 28 Percent In 2016
Boosted By Shorts In Pharma "Price Gouging" Stocks, Raging Capital Up 28 Percent In 2016
Credit Suisse Like Pharma On Tax Changes
What’s Instore For Big Pharma In 2017?
What's Instore For Big Pharma In 2017?
Specialty Pharma Underperforms S&P 500 For First Time Since 2009
Specialty Pharma Underperforms S&P 500 For First Time Since 2009
Moody's: Outlook For Global Pharmaceuticals Stable Despite Growing Anger
Moody’s: Outlook For Global Pharmaceuticals Stable Despite Growing Anger
Visium Balanced Fund Hit By Pharma Stocks Sees Opportunity Ahead
Michael van Biema And Allen Benello On Valeant Pharmaceuticals [Part Two]
Special Committee on Aging Frontruns Valeant Pharmaceuticals Q1 Earnings Release
Valeant Pharmaceuticals Intl Inc (VRX) Tanks As Ackman And Munger Feud
New Valeant Pharmaceuticals Intl Inc Board Sends Message As Firm Reinstates Earnings
MDC Partners Inc (MDCA): Like Valeant Pharmaceuticals, But with Understated Debts

